Events supposedly attributable to vaccination and immunization against COVID-19, in medical staff of a basic hospital.
DOI:
https://doi.org/10.29166/rfcmq.v49i2.6678Keywords:
COVID-19/Mortality;RNA Viruses/Toxicity; Vaccination/Statistics & Numerical data; Pandemic/EpidemiologyAbstract
Introduction: Vaccination was proposed worldwide as a strategy to reduce transmission, complications and death due to SARS-CoV-2 infection; Ecuador, like many countries, began with immunization, prioritizing strategic population groups. Objective: Report post-vaccination symptoms, cataloged as events supposedly attributable to immunization against COVID-19. Materials and methods: Analytical observational study, carried out in medical personnel immunized with two doses of BNT162b2 PFIZER in COVID-19, at the Base Hospital of the Club de Leones Quito Central, between March and May 2021. An online survey was carried out on the symptoms. post vaccination. Results: Of 118 immunized doctors, 71.8% were men, with an average age of 67.2 years. 93.2% were > 60 years old. 58.5% had comorbidities. 44.1% of women presented reactions after the first dose; 70.2% of men and 73.5% of women with the second dose. Age was the only factor associated with local effects with the second dose of the COVID-19 vaccine. Discussion: The adverse reactions identified after vaccination of the first and second doses are similar to previous studies, however, the signs and symptoms after vaccination of the second dose were more frequent, in turn, the symptoms decreased with age. Conclusion: The post-vaccination symptoms, cataloged as events supposedly attributable to immunization against COVID-19, were pain, edema, erythema, headache, fatigue and myalgia among the most predominant.
Downloads
Metrics
References
Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine [Internet]. 2020[ Cited Apr 30, 2024];383(27):2603-2615. Available from: DOI: 10.1056/NEJMoa2034577
Palacios Cruz M, et al. COVID-19, a worldwide public health emergency. Revista Clínica Española [Internet]. 2021[ Cited Apr 30, 2024];221(1): 55-61. Available from: DOI: 10.1016/j.rce.2020.03.001.
Medeiros de Figueiredo A, Daponte A, Moreira Marculino de Figueiredo DC, Gil-García E, Kalache A. Letalidad de la COVID-19: ausencia de patrón epidemiológico [Case fatality rate of COVID-19: absence of epidemiological pattern] Gac Sanit. [Internet]. 2021[ Cited Apr 30, 2024];35(4):355-357. Available from: DOI: 10.1016/j.gaceta.2020.04.001
Mena AC, Casalí P. El sistema de salud ecuatoriano y la COVID-19. Perú [Internet] 2021. [Cited Mar 12,2024]. Available from: https://www.ilo.org›publication› wcms_799790
Comité de Operaciones de Emergencia Nacional. Informe de Situación COVID-19 Ecuador. Informe Situacional. Quito: Ministerio de Salud, COE. Report No. 66 [Internet]. 2020[Cited Mar 12, 2024]. Available from: https://www.gestionderiesgos.gob.ec/wp-content/uploads/2020/12/Informe-de-Situacion-No066-Casos-Coronavirus-Ecuador-11122020.pdf
Ordóñez-León A. Resiliencia urbana y COVID19. El caso de Loja – Ecuador. Cienci América [Internet]. 2021[ Cited Apr 30, 2024];10(2): 66–80. Available from: DOI: 10.33210/ca.v10i2.366.
Cabezas C. Pandemia de la COVID-19: tormentas y retos. Rev. Perú. med. exp. salud pública [Internet]. 2020[ Cited Apr 30, 2024];37(4):603-604. Available from: http://dx.doi.org/10.17843/rpmesp.2020.374.6866
World health organization. COVID-19 Weekly Epidemiological Update [Internet] 2021. [Cited Mar 12, 2024]. Available from: https://www.reliefweb.int
Pozo-Medina A. Desarrollo de vacunas frente al Covid-19: revisión sobre su presente y futuro. España [Internet] 2021. [Cited Mar 15, 2024]. Available from: https://crea.ujaen.es/bitstream/10953.1/14431/1/TFGB%20Antonio%20Pozo%20Medina.pdf
Thomson MG, Burgess JL, et al. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine [Internet]. 2021[ Cited Apr 30, 2024];385:320-329. Available from: DOI: 10.1056/NEJMoa2107058
Ministerio de Salud pública. Plan Nacional de Vacunación e Inmunización contra el COVID – 19. Informe Situacional. Quito: Directora Nacional de Cambio de Cultura Organizacional, Plan Vacunarse Ecuador [Internet]. 2021. [Cited Mar 12, 2024]. Available from: https://www.salud.gob.ec/wp-content/uploads/2021/05/01-Plan-nacional-de-vacunacion-e-inmuniczacion-contra-el-COVID-19-Ecuador-2021-1.pdf
Ministerio de Salud. Comité de Operaciones de Emergencia Nacional. Informe de Situación COVID-19 Ecuador. Informe Situacional. Quito: Report No. 008 [Internet]. 2020[ Cited Apr 30, 2024]. Available from: https://www.gestionderiesgos.gob.ec/wpcontent/uploads/2020/03/Informe-de-Situaci%C3%B3n-No008-Casos-Coronavirus-Ecuador-16032020-20h00.pdf
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria. Reporte de Eventos Atribuibles a la Vacunación no Inmunización (ESAVI) por el Programa ampliado de Inmunizaciones (PAI) al Centro Nacional de Farmacovigilancia (CNFV) [Internet] 2017. [Cited Mar 12,2024]. Available from: https://www.controlsanitario.gob.ec/wp-content/uploads/downloads/2017/08/IE-B.5.1.8-MB 01_externo_ESAVIS_socializacion.pdf
Chico-Sánchez P, Gras-Valentí P, Algado-Sellés N, et al. Efectividad de la vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario [Effectiveness of BNT162b2 vaccine to preventing COVID-19 in healthcare personnel]. Gac Sanit [Internet]. 2022[Cited Apr 30, 2024]; 36(5):484-487. Available from: DOI: 10.1016/j.gaceta.2021.11.003
Organización Mundial de la Salud. Efectos secundarios de las vacunas contra el COVID-19 [Internet] 2021 [Cited Mar 12,2024]. Available from: https://www.who.int/es/news-room/feature-stories/detail/side-effects-of-covid-19-vaccines
Peraza C. Salud laboral frente a la pandemia del COVID-19 en Ecuador. Medisur [Internet]. 2020[Cited Apr 30, 2024];18(3):507-511. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2020000300507&lng=es.
Comité de Operaciones de Emergencia Nacional. Informe de Situación COVID-19 Ecuador. Informe Situacional. Quito: Ministerio de Salud, COE nacional; Report No. 68 [Internet]. 2021 [Cited Mar 12, 2024]. Available from: https://www.gestionderiesgos.gob.ec/wp-content/uploads/2021/01/Informe-de-Situacion-No068-Casos-Coronavirus-Ecuador-15012021.pdf
Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med [Internet]. 2021 [Cited Apr 30,2024];385(12):1078-1090. Available from: DOI: 10.1056/NEJMoa2110475
Shimabukuro T, Nair N. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine. JAMA [Internet]. 2021[Cited Apr 30, 2024];325(8):780-781. Available from: DOI: 10.1001/jama.2021.0600
Risco-Risco C, Martínez-Urbistondo D, Suárez Del Villar R, et al. Influence of epidemiological and clinical factors in the reactogenicity to Comirnaty vaccine in health care workers of a Spanish university teaching hospital (COVIVAC study). Rev Esp Quimioter [Internet]. 2023[Cited Apr 30, 2024];36(4):400-407. Available from: DOI:10.37201/req/017.2023.
Cegolon L, Mauro M, Sansone D, et al. A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity-ORCHESTRA Project. Vaccines (Basel) [Internet]. 2023[Cited Apr 30, 2024];11(12):1769. Available from: DOI: 10.3390/vaccines11121769
Azimi-Nezhad M, Gholami A, Taghiabadi E, Ghodsi H. Short-term Side Effects of COVID-19 Vaccines (Astrazeneca, Sputnik-V, and Sinopharm) in Health Care Workers: A Cross-Sectional Study in Iran. Med J Islam Repub Iran [Internet]. 2022[Cited Apr 30, 2024]; 36:159. Available from: DOI: 10.47176/mjiri.36.159.
Chomali M, Guell M, Hervé B, Angulo M, Huerta C, Gutiérrez C, et al. Impacto de la primera ola pandémica de COVID-19 en el personal de salud en un hospital privado. Rev médica Clín Las Condes [Internet]. 2021[Cited Apr 30, 2024];32(1):90–104. Available from: http://dx.doi.org/10.1016/j.rmclc.2020.12.010
Del Carpio-Orantes L, Garcés-García E, Ortiz-Espinoza C, et al. Médicos de primera línea de atención infectados por COVID-19 durante un brote hospitalario en Veracruz, México. Med Int Mex [Internet]. 2020[Cited Apr 30,2024];36(6):781-788. Available from: https://www.medigraphic.com/cgibin/new/resumen.cgi?IDARTICULO=96463
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Miguel Jacob Ochoa-Andrade
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.